In a study selected as among the top 10% most interesting articles published in the Journal of Immunology, the team identifies the elevated presence in MS patients of a type of white blood cell (CD4 T cell) that expresses NKG2C, a highly-toxic molecule harmful to brain tissues.
In close collaboration with clinicians at the University of Montreal Hospital and the Montreal Neurological Institute, McGill University, Dr. Arbour’s team studied tissues from healthy subjects and MS patients. This approach enabled the team to uncover a novel mechanism by which CD4 T cells expressing NKG2C can directly target brain cells having a specific corresponding ligand found only in MS patients. “These results are very encouraging,” says Arbour, “since they provide us with a much more refined picture of how the brain cells of MS patients are targeted by the immune system and provide us with a clearer understanding of how to go about blocking their action.”
There is no known cure for this auto-immune disease of the central nervous system. While there are a number of approved MS therapies targeting molecules expressed by immune cells, they are sometimes too broad in their application. They can suppress the efficiency of the immune system but also open the way for serious infections in some MS patients such as progressive multifocal leukoencephalopathy, a serious viral disease that can cause death in people with severe immune deficiency, such as MS patients on immunosuppressive medication.
“Our research has made an important step in getting around this problem. Because NKG2C is specifically expressed by a subset of CD4 T cells only found in MS patients, targeting this receptor would not affect large populations of immune cells, but only those which produce the symptoms characteristic of this debilitating disease,” explains Arbour.
For patients this discovery could translate into improved treatments aimed at decreasing the progression of the disease and its symptoms, without the risk of potentially lethal infections and therefore improving their quality of life.
About Multiple Sclerosis
With more than 75,000 Multiple Sclerosis patients, Canada has one of the highest incidences of the disease in the world. The intrusion of the body’s immune system into the brain affects the ability of neurons in the brain and in the spinal cord to communicate efficiently with one another, producing extensive and recurrent central nervous system damage. Multiple Sclerosis symptoms can include paralysis, pricking or numbness, visual problems, difficulties with coordination, balance and movement, which lead to chronic handicap.
About the study
“Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis” was featured in the March 15 issue of the Journal of Immunology, where it was selected as being among the top 10% most interesting articles published in the journal. The research team included basic and clinical scientists from the University of Montreal Hospital and the Montreal Neurological Institute, McGill University.
About Dr. Nathalie Arbour
Dr. Arbour is a researcher in the Neuroscience Axis at the University of Montreal Hospital Research Centre and a Research Associate Professor at the Department of Medicine, University of Montreal. Her research program is funded by the Multiple Sclerosis Society of Canada, the Canada Foundation for Innovation and she currently holds a New Investigator Award from the Canadian Institutes of Health Research.
About the CRCHUM
The University of Montreal Hospital* Research Centre (CRCHUM) improves the health of adults through a high-quality academic research continuum which, by improving our understanding of etiological and pathogenic mechanisms, fosters the development, implementation and assessment of new preventive, diagnostic and therapeutic strategies. The CRCHUM provides a training environment to ensure the development of new generations of researchers committed to research excellence.
*The University of Montreal Hospital and the University of Montreal are known officially as Centre hospitalier de l’Université de Montréal and Université de Montréal, respectively.
About The Neuro
The Montreal Neurological Institute and Hospital - The Neuro, is a unique academic medical centre dedicated to neuroscience. A research and teaching institute of McGill University, The Neuro forms the basis for the Neuroscience Mission of the McGill University Health Centre. Founded in 1934 by Dr. Wilder Penfield, The Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders.
Centre hospitalier de l’Université de Montréal (CHUM)
Sylvie Robitaille | Source: EurekAlert!
Further Reports about: brain cell > brain tissue > CD4+ T cells > CD4-Rezeptor > central nervous system > Centre > health services > Hospital > immune cell > immune system > Immunology > Multiple Sklerose > nervous system > Neuro Film Festival > neurological > Neuroscience > Researchers > T cells
More articles from Health and Medicine:
Changing cancer's environment to halt its spread
22.05.2013 | Boston Children's Hospital
Biodegradable stent proves non-inferior to drug-eluting stent
22.05.2013 | European Society of Cardiology
A fried breakfast food popular in Spain provided the inspiration for the development of doughnut-shaped droplets that may provide scientists with a new approach for studying fundamental issues in physics, mathematics and materials.
The doughnut-shaped droplets, a shape known as toroidal, are formed from two dissimilar liquids using a simple rotating stage and an injection needle. About a millimeter in overall size, the droplets are produced individually, their shapes maintained by a surrounding springy material made of polymers.
Droplets in this toroidal shape made ...
Frauhofer FEP will present a novel roll-to-roll manufacturing process for high-barriers and functional films for flexible displays at the SID DisplayWeek 2013 in Vancouver – the International showcase for the Display Industry.
Displays that are flexible and paper thin at the same time?! What might still seem like science fiction will be a major topic at the SID Display Week 2013 that currently takes place in Vancouver in Canada.
High manufacturing cost and a short lifetime are still a major obstacle on ...
University of Würzburg physicists have succeeded in creating a new type of laser.
Its operation principle is completely different from conventional devices, which opens up the possibility of a significantly reduced energy input requirement. The researchers report their work in the current issue of Nature.
It also emits light the waves of which are in phase with one another: the polariton laser, developed ...
Innsbruck physicists led by Rainer Blatt and Peter Zoller experimentally gained a deep insight into the nature of quantum mechanical phase transitions.
They are the first scientists that simulated the competition between two rival dynamical processes at a novel type of transition between two quantum mechanical orders. They have published the results of their work in the journal Nature Physics.
“When water boils, its molecules are released as vapor. We call this ...
Researchers have shown that, by using global positioning systems (GPS) to measure ground deformation caused by a large underwater earthquake, they can provide accurate warning of the resulting tsunami in just a few minutes after the earthquake onset.
For the devastating Japan 2011 event, the team reveals that the analysis of the GPS data and issue of a detailed tsunami alert would have taken no more than three minutes. The results are published on 17 May in Natural Hazards and Earth System Sciences, an open access journal of ...
22.05.2013 | Life Sciences
22.05.2013 | Ecology, The Environment and Conservation
22.05.2013 | Earth Sciences
17.05.2013 | Event News
15.05.2013 | Event News
08.05.2013 | Event News